GLP-1 Drugs Tied to 31% Lower Diabetes Risk Than Metformin in 256,492 Adults With Prediabetes and Obesity

Adults with prediabetes and obesity who took GLP-1 drugs had lower risks of type 2 diabetes and cardiovascular events than metformin users, though the observational findings remain preliminary.